Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to Osimertinib. Smith JT, Puri S, Akerley W. Clin Lung Cancer 2023;24:360-361.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith JT, Puri S, Akerley W. Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to Osimertinib. Clin Lung Cancer 2023;24:360-361.
PMID: 36935243